Tag Archives: Primary

Pharmacies Grow for Primary Care On-Ramps – And J.D. Power Says Consumers Like That

The use of health and wellness services delivered in retail pharmacies is growing, and health consumers’ satisfaction increases with use. That’s the headline for J.D. Power’s 2020 U.S. Pharmacy Study. This is the 12th year of J.D. Power’s U.S. Pharmacy Study, this year based on a survey of 13,378 pharmacy customers who filled a prescription… Read More »

Can a primary doctor prescribe antidepressants

Depression impacts people in many different ways. Family doctors generally have an understanding of the most common symptoms of depression. Unfortunately, when many of the symptoms of depression are viewed independently, it delays appropriate treatment. Depression does not treat everyone equally. Because of this, seeking professional treatment is crucial to healing and managing depressive illness.… Read More »

Hospitals, doctors and Gawande laud new CMS primary care model, but will practices stay?

The new CMS primary care payment program unveiled this week won tentative buy-in from doctors, hospitals and healthcare players across the political spectrum. The so-called Primary Cares Initiative set lofty goals, including getting a quarter of providers and beneficiaries to sign up. The program, however, is fully voluntary, and some paths carry significant downside risk. That… Read More »

FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis

FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis Print this page November 20, 2018 — The U.S. Food and Drug Administration today approved Gamifant (emapalumab) for the treatment of pediatric (newborn and above) and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) who have refractory, recurrent or progressive disease or intolerance with conventional HLH therapy. This… Read More »